according to the World Health Organization, 130-175 million inhabitants worldwide are infected with hepatitis C (HCV) virus, which causes more than 350,000 deaths each year. Chronic HCV is a major cause of cirrhosis, hepatocellular carcinoma (liver cancer), and the last stage of liver disease. In this article, you will get acquainted with the mechanics of infection of the hepatitis C virus ( HCV) into the human body, one of the most dangerous viruses currently, with cases of infestation and inflammation that it produces after infection. You can get information about the changes that the hepatitis C virus ( HCV) makes in the blood cells of patients and their pathology.

HCV, liver cirrhosis, hepatocellular carcinoma, hepatocyte, ALT, AST, anti-HCV, bilirubin levels, thrombocytopenia, autoimmune hypothyroidism, rheumatoid arthritis, glomerulonephritis, and thyroiditis.

Centers for Disease Control and Prevention, 2016. Viral Hepatitis - Hepatitis C Information. Hepatitis C FAQs For Health Professionals. Accessed April 26, 2016.

Pietschmann, T., Brown, R. J. P. (2019). Hepatitis C virus. Trends Microbiol. 27, 379–380. doi: 10.1016/j.tim.2019.01.001

IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-ISSN: 2320–1959.p- ISSN: 2320–1940 Volume 6, Issue 5 Ver. I. (Sep. -Oct .2017), PP 41-45

www.iosrjournals.org

Frontiers | The association between hepatitis C virus infection status and blood pressure in adults in the United States: NHANES 1999–2012

https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2024.1401323/full#B42

Seeff L.B., Everson G.T., Morgan T.R., Curto T.M., Lee W.M., Ghany M.G., Shiffman M.L., Fontana R.J., Di Bisceglie A.M. and Bonkovsky H.L., 2010. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clinical Gastroenterology and Hepatology, 8:10:877-883.

Karasu Z., Tekin F., Ersoz G., Gunsar F., Batur Y., Ilter T. and Akarca U.S., 2007. Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C. Digestive diseases and sciences, 52:6:1535-1539

Gumbert S.C. and Chopra S., 1995: Hepatitis C: a multifaceted disease: Review of extrahepatic manifestations (Review). Ann Intern Med, 123:8:615-620.

Cacoub P., Poynard T., Ghillani P., Charlotte F., Olivi M., and Piette J.C., 1999. Extrahepatic manifestations of chronic hepatitis C: MULTIVIRC Group: multidepartment Virus C. Arthritis Rheum, 42:10:2204-2212.

Nocente R., Ceccanti M., Bertazzoni G., Cammarota G., Silveri N.G. and Gasbarrini G., 2003. HCV infection and extrahepatic manifestations (Review). Hepatogastroenterology, 50:52: 1149-1154.

Iolascon A., d'Apolito M., Servedio V., Cimmino F., Piga A. and 1*44444Camaschella C., 2005. Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood, 107:1:349-54.